 |
 Materials Available for Your Patients
A number of helpful patient materials are available to you for distribution to your patients who are referred for myocardial perfusion imaging. You can download a detailed guide that will help your patients understand myocardial perfusion imaging tests (see Patient Guide to Myocardial Perfusion Imaging below—available in both English and Spanish).
Astellas offers a complimentary patient education video that you can use to show your patients how myocardial perfusion imaging is performed. Order your copy of the video by calling the number below. To view an excerpt from the program, click here.
Other materials for your patients are available that address topics including how heart disease develops, how myocardial perfusion imaging works, and what the test results mean. To obtain the patient materials, contact Astellas Pharma US, Inc., at 1-800-888-7704, or contact your Astellas sales representative.
Patient Guide to Myocardial Perfusion Imaging
This guide is intended for use with your patients to help them understand myocardial perfusion imaging.
Click here to download the Patient Guide (PDF file, 690K).
Click here to download the Patient Guide in Spanish. (PDF file, 690K)
|
IMPORTANT SAFETY INFORMATION Intravenous Adenoscan® (adenosine injection) is indicated as an adjunct to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately.
Adenoscan is contraindicated in patients with 2nd- or 3rd-degree AV block, sinus node disease, and known or suspected bronchoconstrictive or bronchospastic lung disease.
Approximately 2.6% and 0.8% of patients developed second- and third-degree AV block, respectively. All episodes of AV block have been asymptomatic, transient, and did not require intervention; less than 1% required termination of adenosine infusion.
Fatal cardiac arrest, sustained ventricular tachycardia (requiring resuscitation), and nonfatal myocardial infarction have been reported coincident with Adenoscan infusion. Patients with unstable angina may be at greater risk.
Side effects that were seen most often included flushing (44%), chest discomfort (40%), and dyspnea (28%). Side effects usually resolve quickly when infusion is terminated and generally do not interfere with test results.
Despite adenosine’s short half-life, 10.6% of the side effects started several hours after the infusion terminated, and 8.4% of the side effects that began during the infusion persisted for up to 24 hours after infusion. In many cases, it is not possible to know whether these late adverse events are the result of Adenoscan infusion. Please see full prescribing information. |
|
Patient Education Video
This informative and easy-to-understand video explains the myocardial perfusion imaging procedure and how it is used to detect coronary artery disease. Click here to view a brief excerpt.
|
|
|